Redhill Biophrma ADR (RDHL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2016 | 03-2016 | 12-2015 | 09-2015 | 06-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -12,076 | -5,524 | -21,090 | -14,530 | -11,238 |
| Depreciation Amortization | 21 | 10 | 30 | 26 | 17 |
| Accounts payable and accrued liabilities | 323 | 68 | 153 | 500 | 367 |
| Other Working Capital | 1,433 | 508 | 2,570 | 2,343 | 1,869 |
| Other Operating Activity | -419 | -43 | 517 | -137 | 933 |
| Operating Cash Flow | $-10,718 | $-4,981 | $-17,820 | $-11,798 | $-8,052 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -7,480 | -4,572 | -29,500 | -9,500 | -2,000 |
| PPE Investments | -45 | -29 | -10 | -13 | -7 |
| Purchase Sale Intangibles | N/A | N/A | -1,620 | -1,620 | -1,575 |
| Other Investing Activity | 0 | 0 | 8,320 | 8,380 | -1,575 |
| Investing Cash Flow | $-7,525 | $-4,601 | $-21,190 | $-1,133 | $-3,582 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 110 | 10 | 54,792 | 54,758 | 13,234 |
| Other Financing Activity | 0 | 0 | -2 | 0 | 0 |
| Financing Cash Flow | $110 | $10 | $54,790 | $54,758 | $13,234 |
| Exchange Rate Effect | 41 | 82 | -150 | -136 | -53 |
| Beginning Cash Position | 21,516 | 21,516 | 5,890 | 5,892 | 5,892 |
| End Cash Position | 3,424 | 12,026 | 21,510 | 47,583 | 7,439 |
| Net Cash Flow | $-18,092 | $-9,490 | $15,620 | $41,691 | $1,547 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,718 | -4,981 | -17,820 | -11,798 | -8,052 |
| Capital Expenditure | -45 | -29 | -14 | -13 | -7 |
| Free Cash Flow | -10,763 | -5,010 | -17,834 | -11,811 | -8,059 |